166 related articles for article (PubMed ID: 34395261)
1. The Survival Effect of Radiotherapy on Stage II/III Rectal Cancer in Different Age Groups: Formulating Radiotherapy Decision-Making Based on Age.
Li Y; Liu H; Zhou Y; Zhou Z; Liu W; Zhao L; Güngör C; Wang D; Pei Q; Pei H; Tan F
Front Oncol; 2021; 11():695640. PubMed ID: 34395261
[TBL] [Abstract][Full Text] [Related]
2. The Survival Effect of Radiotherapy on Stage IIB/III Pancreatic Cancer Undergone Surgery in Different Age and Tumor Site Groups: A Propensity Scores Matching Analysis Based on SEER Database.
Wang D; Ge H; Tian M; Li C; Zhao L; Pei Q; Tan F; Li Y; Ling C; Güngör C
Front Oncol; 2022; 12():799930. PubMed ID: 35174085
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
[TBL] [Abstract][Full Text] [Related]
4. The main contributor to the upswing of survival in locally advanced colorectal cancer: an analysis of the SEER database.
Li Y; Zhao L; Güngör C; Tan F; Zhou Z; Li C; Song X; Wang D; Pei Q; Liu W
Therap Adv Gastroenterol; 2019; 12():1756284819862154. PubMed ID: 31360223
[TBL] [Abstract][Full Text] [Related]
5. Impact of Duration of Neoadjuvant Radiation on Rectal Cancer Survival: A Real World Multi-center Retrospective Cohort Study.
Abdel-Rahman O; Kumar A; Kennecke HF; Speers CH; Cheung WY
Clin Colorectal Cancer; 2018 Mar; 17(1):e21-e28. PubMed ID: 28709877
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
[TBL] [Abstract][Full Text] [Related]
7. Overall Survival Benefit in Rectal Cancer After Neoadjuvant Radiotherapy and Adjuvant Chemotherapy: A Propensity-Matched Population-Based Study.
Chen Z; Li S; Wang Y; Fu Z; Liu N; Wang H; Liu X
Front Oncol; 2020; 10():584835. PubMed ID: 33363014
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant Chemotherapy Seemed Not to Have Survival Benefit in Rectal Cancer Patients with ypTis-2N0 After Preoperative Radiotherapy and Surgery from a Population-Based Propensity Score Analysis.
Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
Oncologist; 2019 Jun; 24(6):803-811. PubMed ID: 29674444
[TBL] [Abstract][Full Text] [Related]
9. Survival Benefit of Preoperative Versus Postoperative Radiotherapy in Metastatic Rectal Cancer Treated With Definitive Surgical Resection of Primary Tumor: A Population Based, Propensity Score-Matched Study.
Luo D; Liu Q; Zhu J; Ma Y; Cai S; Li Q; Li X
J Cancer; 2019; 10(5):1307-1312. PubMed ID: 30854140
[TBL] [Abstract][Full Text] [Related]
10. Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis.
Wang D; Liu C; Zhou Y; Yan T; Li C; Yang Q; Xu Y; Zhao L; Pei Q; Tan F; Güngör C; Li Y
Radiat Oncol; 2020 May; 15(1):107. PubMed ID: 32404114
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant Radiotherapy Versus Surgery Alone for Stage II/III Mid-low Rectal Cancer With or Without High-risk Factors: A Prospective Multicenter Stratified Randomized Trial.
Deng X; Liu P; Jiang D; Wei M; Wang X; Yang X; Zhang Y; Wu B; Liu Y; Qiu M; Zhuang H; Zhou Z; Li Y; Xu F; Wang Z
Ann Surg; 2020 Dec; 272(6):1060-1069. PubMed ID: 31599809
[TBL] [Abstract][Full Text] [Related]
12. The survival impact of radiotherapy on synchronous metastatic rectal cancer: metastatic site can serve for radiotherapy-decision.
Zhou Y; Wang D; Tan F; Zhou Z; Zhao L; Güngör C; Pei Q; Li Y; Liu W
J Cancer; 2022; 13(7):2171-2178. PubMed ID: 35517420
[No Abstract] [Full Text] [Related]
13. A large-scale study integrating nutritional indicators and clinicopathological parameters to evaluate prognosis, follow-up, and postoperative chemotherapy decisions in rectal cancer patients.
Yu Y; Wu J; Wu H; Wang Z; Wu S; Hong L; Xu B; Shao L
Support Care Cancer; 2023 Nov; 31(12):686. PubMed ID: 37945781
[TBL] [Abstract][Full Text] [Related]
14. Marital status and survival in patients with rectal cancer: An analysis of the Surveillance, Epidemiology and End Results (SEER) database.
Wang X; Cao W; Zheng C; Hu W; Liu C
Cancer Epidemiol; 2018 Jun; 54():119-124. PubMed ID: 29727804
[TBL] [Abstract][Full Text] [Related]
15. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.
Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB
Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919
[TBL] [Abstract][Full Text] [Related]
16. Stage selection for neoadjuvant radiotherapy in non-cervical esophageal cancer: A propensity score-matched study based on the SEER database.
Ma K; Yang Y; Wang S; Yang X; Lu T; Xi J; Jiang W; Zhan C; Zhu Y; Wang Q
Thorac Cancer; 2018 Sep; 9(9):1111-1120. PubMed ID: 29961955
[TBL] [Abstract][Full Text] [Related]
17. Preoperative radiotherapy improves survival in rectal signet-ring cell carcinoma-a population-based study.
Wu SG; Zhang WW; Sun JY; He ZY; Su GQ; Li FY
Radiat Oncol; 2017 Aug; 12(1):141. PubMed ID: 28835256
[TBL] [Abstract][Full Text] [Related]
18. Can Elevated Pretreatment Serum Carcinoembryonic Antigen Levels Serve as a Potential Biomarker Guiding Adjuvant Chemotherapy in Rectal Cancer Patients With ypTis-3N0 After Neoadjuvant Radiotherapy and Surgery?
Huang C; Jiang M; Li Y; Tang C; Ma X; Huan X
Front Oncol; 2021; 11():705460. PubMed ID: 34414115
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant radiotherapy improves cause specific survival in stage II, not stage III mucinous carcinoma of the rectum.
Li Q; Li Y; Dai W; Wang S; Xu Y; Li X; Cai S
BMC Cancer; 2017 Jan; 17(1):80. PubMed ID: 28122523
[TBL] [Abstract][Full Text] [Related]
20. Alternative clinical end points in rectal cancer--are we getting closer?
Glynne-Jones R; Mawdsley S; Pearce T; Buyse M
Ann Oncol; 2006 Aug; 17(8):1239-48. PubMed ID: 16873440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
